Edessa vs HealthSource
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A six-month committer, or anyone willing to click past the homepage to the table with the real monthly rate.
- semaglutide
- $179/mo
- tirzepatide
- $239/mo
Before enrolling
The homepage leads with "Start for just $135", a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239.
Desk Score
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
- semaglutide
- $199 per 4 weeks
- tirzepatide
- $299 per 4 weeks
Before enrolling
You pay before the medical intake — the questionnaire link appears only after checkout, and withdrawing once you have filled it in costs you $25–$45 for the provider review
Our review of HealthSource gives it 84/100 (B), while our review of Edessa gives it 74/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
74/100
C
84/100
B
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Edessa | HealthSource |
|---|---|---|
| Semaglutide | $179/moFull plan terms$179/mo month-to-month injectable (compounded; $135 only on a 6-month prepay) | $199 per 4 weeksFull plan terms$199 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Tirzepatide | $239/moFull plan terms$239/mo month-to-month (compounded; $209 only on a 6-month prepay) | $299 per 4 weeksFull plan terms$299 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Coverage | Not confirmed for Edessa. | All 50 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | A six-month committer, or anyone willing to click past the homepage to the table with the real monthly rate. | Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks. |
| Desk Score | 74/100C | 84/100B |
The verdict
Desk pick — HealthSourceHealthSource has the higher Desk Score, but Edessa may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
A six-month committer, or anyone willing to click past the homepage to the table with the real monthly rate.
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Edessa
- CoreAge Rx vs HealthSource
- Curex vs Edessa
- Curex vs HealthSource
- Bodybuilding Health+ vs Edessa
- BetterMe Rx vs HealthSource
Or see the full comparison hub and the complete ranking.